French Travelers' Knowledge of Risk of Acquiring ESBL-PE

NCT03339947 | Completed

• 1 other identifier: 2016Ao006
• Study Type: observational
• Target: 191
• Locations: 1 country
• Sites: 1

Brief Summary

Since it is not routine practice in France to raise public awareness about the risk of acquiring multidrug resistant Enterobacteriaceae (MRE) during international travel, the investigators aimed to determine, among French travelers attending a consultation for travel medicine, patients level of knowledge about the risk of acquiring MRE.

Conditions

Travel Medicine

Keywords

Multidrug-resistant Enterobacteriaceae acquisition; travellers' diarrhoea; international travel

Outcome Measures

Primary Outcomes (1)

• Level of knowledge regarding multidrug resistant Enterobacteriaceae

  The questionnaire was completed before the planned travel and recorded information on the patient's knowledge of the definition of multidrug resistant bacteria (MDR), knowledge of the factors associated with acquiring MDR bacteria, consumption of antibiotics during previous travel, awareness of the need to inform health professionals about the recent trip in case of health problems after return, perceived need for more information about MDR bacteria, desired source of such information. The questions about knowledge were designed to be as simple as possible, with closed answers ('yes', 'no', 'don't know')

  Day 1

Study Arms (1)

Travel medicine

All adult travellers who attended the consultation for travel medicine and international vaccination in Reims University Hospital.

Other: Questionnaire

Interventions

Questionnaire OTHER

Travel medicine

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

All adult travellers who attended the consultation for travel medicine and international vaccination in Reims University Hospital between January 2016 and May 2016 and who completed the questionnaire were included in the study.

You may qualify if:

• Adult travellers who attended the consultation for travel medicine and international vaccination in Reims University Hospital
• Adult who completed the questionnaire

Sponsors & Collaborators

• CHU de Reims: lead

Study Sites (1)

Damien JOLLY

Reims, France

Location

Related Publications (1)

• Migault C, Kanagaratnam L, Nguyen Y, Lebrun D, Giltat A, Hentzien M, Bajolet O, Drame M, Bani-Sadr F. Poor knowledge among French travellers of the risk of acquiring multidrug-resistant bacteria during travel. J Travel Med. 2016 Oct 30;24(1):taw073. doi: 10.1093/jtm/taw073. Print 2016 Jul. No abstract available.

  PMID: 27799500 BACKGROUND

MeSH Terms

Interventions

Surveys and Questionnaires

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 8, 2017
• First Posted: November 13, 2017
• Study Start: January 1, 2016
• Primary Completion: May 1, 2016
• Study Completion: June 1, 2016
• Last Updated: November 13, 2017

Record last verified: 2017-11

Locations

FR (1)